SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-006509
Filing Date
2022-05-12
Accepted
2022-05-12 09:41:42
Documents
18
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr_8k.htm   iXBRL 8-K 24020
2 EXHIBIT mnpr_ex991.htm EX-99.1 17999
8 mnpr_ex991img3.jpg GRAPHIC 4996
9 mnpr_ex991img2.jpg GRAPHIC 929
10 mnpr_ex991img1.jpg GRAPHIC 873
  Complete submission text file 0001654954-22-006509.txt   183718

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20220512.xsd EX-101.SCH 5845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20220512_lab.xml EX-101.LAB 15313
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20220512_cal.xml EX-101.CAL 908
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20220512_pre.xml EX-101.PRE 9750
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20220512_def.xml EX-101.DEF 2113
12 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_8k_htm.xml XML 3705
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 22916088
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences